Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 1/20 | 0.34 |
| ▸ | CFTR | P13569 | 3/20 | 0.33 |
| ▸ | RORC | P51449 | 2/20 | 0.32 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.31 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24984865 | 0.92 | CFTR (0.38) | GRM2CFTRRORCPDE3BPDE3A | |
| SCHEMBL23905373 | 0.91 | GRM2 (0.35) | GRM2CFTRRORCPDE3BPDE3A | |
| SCHEMBL23905836 | 0.91 | GRM2 (0.35) | GRM2CFTRRORCPDE3BPDE3A | |
| SCHEMBL23904728 | 0.89 | CFTR (0.35) | GRM2CFTRRORCPDE3BPDE3A | |
| SCHEMBL23905474 | 0.89 | CFTR (0.35) | GRM2CFTRRORCPDE3BPDE3A | |
| SCHEMBL24987997 | 0.88 | GRM2 (0.37) | GRM2CFTRRORCPDE3BPDE3A | |
| SCHEMBL31412429 | 0.88 | GRM2 (0.37) | GRM2CFTRRORCPDE3BPDE3A | |
| SCHEMBL23904755 | 0.88 | CFTR (0.33) | CFTR | |
| SCHEMBL23904764 | 0.88 | CFTR (0.33) | CFTR | |
| SCHEMBL23905656 | 0.87 | CFTR (0.37) | GRM2CFTRRORCPDE3BPDE3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021198981-A1 | ANTIVIRAL COMPOUNDS AND USES THEREOF | Janssen Biopharma, Inc. (US) | 2021-10-07 | — | — | WO | disclosed |